David Rolfe Alcon Inc Transaction History

Wedgewood Partners Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$68.18 - $87.25 $3.74 Million - $4.79 Million	-54,875 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$66.27 - $76.21 $14.4 Million - $16.6 Million	-217,262 Reduced 79.84%	54,875 $3.86 Million
Q1 2021 May 17, 2021	SELL	$65.32 - $76.01 $1.13 Million - $1.32 Million	-17,361 Reduced 6.0%	272,137 $19.1 Million
Q4 2020 Feb 12, 2021	SELL	$56.82 - $66.57 $918,324 - $1.08 Million	-16,162 Reduced 5.29%	289,498 $19.1 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $62.39 $810,886 - $916,009	-14,682 Reduced 4.58%	305,660 $17.4 Million
Q2 2020 Aug 14, 2020	SELL	$49.45 - $64.16 $1.13 Million - $1.47 Million	-22,900 Reduced 6.67%	320,342 $18.4 Million
Q1 2020 May 15, 2020	SELL	$39.86 - $63.46 $4.88 Million - $7.77 Million	-122,493 Reduced 26.3%	343,242 $17.4 Million
Q4 2019 Feb 14, 2020	SELL	$55.04 - $59.27 $10.3 Million - $11.1 Million	-186,632 Reduced 28.61%	465,735 $26.3 Million
Q3 2019 Nov 14, 2019	BUY	$58.2 - $62.42 $11.7 Million - $12.6 Million	201,343 Added 44.64%	652,367 $38 Million
Q2 2019 Aug 14, 2019	BUY	$54.43 - $63.33 $24.5 Million - $28.6 Million	451,024 New	451,024 $28 Million

709

256M

2.51M

2.06M

Ticker ALC
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 490,087,008
Market Cap $48.1B
Description
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...

Get notified when there are updates to the investment portfolio of Wedgewood Partners Inc, based on Form 13F filings with the SEC.

Stay updated on Wedgewood Partners Inc and David Rolfe with notifications on news.